Baserat på den årliga World Silver Survey som publicerades av Silver Institute och Metals Focus under våren, minskade den globala efterfrågan på silver något under 2025 jämfört med 2024.
Vi har inte gjort några betydande revideringar av våra estimat för Spinnova, även om företaget verkar ha gjort framsteg i sin strategi, både när det gäller att samla ett samarbetskonsortium kring teknologin och att verifiera sänkningen av produktions- och investeringskostnaderna för teknologin.
* Market conditions remain soft * We lower '26e-'27e adj. EBIT by 1-4% * 11x-9x '26e-'27e EV/EBIT adj. Positive signals in Sweden, but volumes await The Nordic consultancy downturn has lasted longer than most anticipated, and while early signs of stabilisation...
Cereno Scientific has reported a SEK60m capital raise through a directed share issue of c 11.8m new B-shares at SEK5.10/share. Notably, the financing was concluded at a 4.1% premium to the previous closing price (SEK4.9) and without any attached warrants...
* Renewed SEK 74m order with EU NATO customer (Ovzon-3 related) * 100% SATCOM (5-months); deliveries start 1 Aug'26 * Supports our estimates; potential for more orders A welcomed order announcement Ovzon has signed a SEK 74m renewal order from the defence...
* Q2e: some GLP-1 ramp-up, more to come in H2e * Estimates up on FX and higher growth in Engineered * Trading at 13x '26e EV/EBITA vs. historical average of 15x Q2e: slight organic acceleration, more to come in H2e We expect Nolato to report Q2 net sales...
CHOSA Oncology’s CCO and board member Claus Frisenberg Pedersen visits Västra Hamnen and discusses the latest developments, what benefit CHOSA brings to cancer patients and how the company creates shareholder value. CHOSA is exercising its TO2 warrants...